Thomas H Dawson

Summary

Affiliation: United States Naval Academy
Country: USA

Publications

  1. ncbi Scaling adult doses of antifungal and antibacterial agents to children
    Thomas H Dawson
    US Naval Academy, Annapolis, Maryland, USA
    Antimicrob Agents Chemother 56:2948-58. 2012
  2. ncbi Scaling laws for capillary vessels of mammals at rest and in exercise
    Thomas H Dawson
    United States Naval Academy, 590 Holloway Road, Annapolis, MD 21402, USA
    Proc Biol Sci 270:755-63. 2003
  3. ncbi Modeling of vascular networks
    Thomas H Dawson
    United States Naval Academy, 590 Holloway Road, Annapolis, MD, 21402, USA
    J Exp Biol 208:1687-94. 2005
  4. ncbi Scaling laws for plasma concentrations and tolerable doses of anticancer drugs
    Thomas H Dawson
    U S Naval Academy, Annapolis, Maryland 21401, USA
    Cancer Res 70:4801-8. 2010

Detail Information

Publications4

  1. ncbi Scaling adult doses of antifungal and antibacterial agents to children
    Thomas H Dawson
    US Naval Academy, Annapolis, Maryland, USA
    Antimicrob Agents Chemother 56:2948-58. 2012
    ....
  2. ncbi Scaling laws for capillary vessels of mammals at rest and in exercise
    Thomas H Dawson
    United States Naval Academy, 590 Holloway Road, Annapolis, MD 21402, USA
    Proc Biol Sci 270:755-63. 2003
    ..Measurements are presented supporting the results. Physiological changes accompanying strenuous exercise are accounted for by a change in the scaling law for capillary number, from scaling exponent 5/8 to 3/4...
  3. ncbi Modeling of vascular networks
    Thomas H Dawson
    United States Naval Academy, 590 Holloway Road, Annapolis, MD, 21402, USA
    J Exp Biol 208:1687-94. 2005
    ..The applicability of the relations is illustrated using existing measurements. Discussion is also included on the effect of strenuous exercise on the scaling law for number of capillary vessels and matters related to it...
  4. ncbi Scaling laws for plasma concentrations and tolerable doses of anticancer drugs
    Thomas H Dawson
    U S Naval Academy, Annapolis, Maryland 21401, USA
    Cancer Res 70:4801-8. 2010
    ..o. administered prodrug capecitabine, the gene silencing inhibitor zebularine, and the blood vessel inhibitor bevacizumab. Scaling considerations for the modern practice of combination chemotherapy are also discussed...